-
V-01 as a Sequential Booster Can Produce Good Protection against Omicron ---- Latest Phase III Data of COVID-19 Vaccine by Livzon Pharma
PharmaSources.com
February 21, 2022
Global pandemic control is still facing enormous challenges after more than two years since the outbreak of the COVID-19.
-
First study to show waning effectiveness of 3rd dose of mRNA vaccines
WorldPharmaNews
February 14, 2022
A nationwide study from the U.S. Centers for Disease Control and Prevention (CDC) is the first to show that immunity against severe COVID-19 disease begins to wane 4 months after receipt of the third dose of an mRNA vaccine (Pfizer or Moderna).
-
Lilly's Bebtelovimab Receives EUA to Treat COVID-19
contractpharma
February 14, 2022
bebtelovimab is an antibody that demonstrates neutralization against the Omicron variant.
-
FDA Approves New Antibody Drug to Fight Omicron Variant
drugs.com
February 11, 2022
The U.S. Food and Drug Administration on Friday gave the nod for a new monoclonal antibody treatment that works against the omicron variant.
-
Three exposures to spike protein allow people to develop broad antibody immunity - also against Omicron
WorldPharmaNews
February 07, 2022
Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is capable of neutralizing even Omicron after a total of three exposures to the viral spike protein.
-
Moderna starts trial for Omicron-specific booster shot
ExpressPharma
January 29, 2022
The company said while a third shot of its original coronavirus vaccine increased neutralising antibodies against the variant at the lower dose, their levels declined six months after the booster dose was administered...
-
Months After Moderna Booster, Antibodies Decline Faster With Omicron
drugs.com
January 27, 2022
An initial surge in antibody levels against the Omicron variant after a booster dose of the Moderna COVID vaccine wanes within six months..
-
Moderna Begins Testing Booster Shot Aimed at Omicron
drugs.com
January 27, 2022
Moderna Inc. announced Wednesday that it has launched a trial that will study the power of a redesigned booster shot
-
Scientists Watch, Worry About New 'Stealth' Version of Omicron Variant
drugs.com
January 27, 2022
A "stealthier" version of the omicron variant that has been spotted in the United States and dozens of other countries...
-
Omicron relief: Pfizer and BioNTech initiate study into targeted vaccine
pharmatimes
January 26, 2022
COVID-19 vaccine luminaries Pfizer and BioNTech study will examine data from the current booster and consider need for specific Omicron jab。